Multiple studies have reported the upregulation of GOLPH3 in various cancers, strongly associating it with tumor advancement, metastasis, and patient prognosis (Kuna and Field, 2019; Song et al., 2021). This evidence concerns the gene GOLPH3 and neoplasm.